YEARS OF POTENTIAL LIFE LOST FROM CARDIOVASCULAR DISEASES OF THE ECONOMICALLY ACTIVE RUSSIAN POPULATION IN 2013-2019
Aim. To analyze the changes in years of potential life lost (YPLL) from cardiovascular diseases (CVDs) of the economically active Russian population in 2013-2019. Material and methods. YPLL was estimated according to the Global Burden of Disease reports at the age of 15-72 years for 2013-2019. The required data were obtained from the annual reports of Federal State Statistics Service. Nonstandardized YPLL was estimated using the following equation: YPLL= ƩDi x ai, where Di is the absolute number of deaths at age I, ai - years not lived. The calculation was carried out for all-cause mortality and separately for CVDs (coronary artery disease (CAD), myocardial infarction (MI), cerebrovascular diseases, bleeding and strokes, and other CVDs). Results. In 2013-2019, there is a decrease in YPLL from all causes, including CVDs. In 2013, YPLL amounted to 14,918,7 years per 100000 economically active population, while in 2019 - 12199,9 years; from CVDs - 4471,6 and 3748,1 years, respectively. YPLL from CAD decreased by 21,5%, from MI - by 23,9%, from bleeding and strokes - by 17%. The rate of YPLL decline in 2014 compared to 2013 was 0,9%. Further, the rate of decline increased, reaching a maximum of 7,6% in 2017 compared to 2016. The differences in YPLL from all causes and CVDs between men and women are almost threefold, as well as from MI and CAD - 4,4 and 3,8 times, respectively. The contribution of CVDs to YPLL from all causes amounted to a maximum of 30,8% in 2018. The contribution of CAD to YPLL from CVDs decreased from 48,0% in 2013 to 44,9% in 2019. The contribution of MI to YPLL from CVDs in men (in 2019, 8%) is less than the contribution of alcoholic and unspecified cardiomyopathy (13,6%), while in women - 5,6% and 11,4%, respectively. There are no data on deaths from heart defects. Conclusion. The change in the YPLL from specific CVD causes occurs unevenly (by year and sex). MI, deaths from which is one of the key parameters of targeted mortality reduction programs, has a smaller effect on the YPLL level than cardiomyopathy, including alcoholic. To reduce mortality and YPLL at the economically active age, it is necessary to correct target programs.